Mediclinic International PLC (LON:MDC) has earned a consensus recommendation of “Hold” from the eight research firms that are presently covering the stock. Seven equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is GBX 964.43 ($11.75).
MDC has been the subject of several research reports. Citigroup Inc. upgraded shares of Mediclinic International PLC to a “buy” rating and upped their price target for the company from GBX 990 ($12.07) to GBX 1,150 ($14.02) in a research report on Tuesday, June 28th. Jefferies Group upped their price objective on shares of Mediclinic International PLC from GBX 833 ($10.15) to GBX 920 ($11.21) and gave the stock a “hold” rating in a research report on Tuesday, July 26th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 1,160 ($14.14) price objective on shares of Mediclinic International PLC in a research report on Tuesday, August 23rd.
Mediclinic International PLC (LON:MDC) traded down 1.97% during trading on Monday, hitting GBX 896.50. 1,162,739 shares of the stock traded hands. The stock’s market cap is GBX 6.61 billion. Mediclinic International PLC has a 52-week low of GBX 794.50 and a 52-week high of GBX 1,219.00. The company’s 50 day moving average price is GBX 947.06 and its 200-day moving average price is GBX 964.99.
Mediclinic International PLC Company Profile
Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.